Browse Title Index
| Issue | Title | |
| Vol 9, No 1 (2018) | The role of viral infection induced alloreactivity in patients with allogeneic hematopoietic stem cell transplantations | Abstract PDF (Polish) |
| Mateusz Maciej Sowiński, Alicja Bukowska | ||
| Vol 12, Supp. C (2021) | The use of midostaurin in aggressive systemic mastocytosis (ASM) with the c-KIT D816V mutation within The Emergency Access to Drug Technologies Programme | Abstract PDF (Polish) |
| Alan Majeranowski, Andrzej Mital | ||
| Vol 12, No 2 (2021) | The use of midostaurin in aggressive systemic mastocytosis (ASM) with the c-KIT D816V mutation within The Emergency Access to Drug Technologies Programme | Abstract PDF |
| Alan Majeranowski, Andrzej Mital | ||
| Vol 12, Supp. C (2021) | The use of midostaurin in the treatment of advanced systemic mastocytosis | Abstract PDF (Polish) |
| Marek Hus, Aneta Szudy-Szczyrek, Justyna Kozińska, Oliwia Bachanek-Mitura | ||
| Vol 12, No 2 (2021) | The use of midostaurin in the treatment of advanced systemic mastocytosis | Abstract PDF |
| Marek Hus, Aneta Szudy-Szczyrek, Justyna Kozińska, Oliwia Bachanek-Mitura | ||
| Vol 11, No 2 (2020) | The use of ponatinib in patient with prior imatinib treatment failure and toxicity of dasatinib | Abstract PDF (Polish) |
| Michał Janowski, Edyta Paczkowska | ||
| Vol 1, No 3 (2010) | The use of tyrosine kinase inhibitors in the second line treatment of patients with chronic myeloid leukemia | Abstract PDF (Polish) |
| Aleksander B. Skotnicki, Tomasz Sacha, Kajetana Foryciarz | ||
| Vol 1, No 1 (2010) | The WHO (2008) classification of B-cell lymphomas - basics and important changes | Abstract PDF (Polish) |
| Monika Prochorec-Sobieszek | ||
| Vol 7, No 4 (2016) | The WHO 2016 classification of B-cell lymphomas — important changes | Abstract PDF (Polish) |
| Monika Prochorec-Sobieszek | ||
| Vol 2, Supp. B (2011) | Therapeutic difficulties in the patient with coexistance of chronic myeloid leukemia and plasma cell myeloma | Abstract PDF (Polish) |
| Ilona Seferyńska, Monika Prochorec-Sobieszek, Krzysztof Warzocha | ||
| Vol 13, No 3-4 (2022) | Therapeutic options in high-risk myelodysplastic syndrome | Abstract PDF |
| Marcela Maksymowicz, Sara Moqbil, Piotr Machowiec, Monika Podhorecka | ||
| Vol 9, No 4 (2018) | Therapeutic plasmapheresis in clinical practice | Abstract PDF (Polish) |
| Beata Wiśniewska | ||
| Vol 2, No 2 (2011) | Therapy of relapsed and refractory plasma cell myeloma | Abstract PDF (Polish) |
| Krzysztof Jamroziak | ||
| Vol 5, No 2 (2014) | Therapy-related acute myeloid leukemia — the risk factors and treatment | Abstract PDF (Polish) HTML (Polish) |
| Sebastian Grosicki | ||
| Vol 2, No 4 (2011) | Thrombocytopenia associated with HCV, HIV and Helicobacter pylori infections | Abstract PDF (Polish) |
| Jacek Treliński, Krzysztof Chojnowski | ||
| Vol 4, No 1 (2013) | Thrombocytosis and thromboembolic complications | Abstract PDF (Polish) |
| Jacek Treliński | ||
| Vol 4, No 1 (2013) | Thromboembolic complications in neoplastic disease — management recommendations of the Institute of Hematology and Transfusion Medicine | Abstract PDF (Polish) |
| Jerzy Windyga | ||
| Vol 4, No 1 (2013) | Thrombotic complications in Philadelphia-negative myeloproliferative neoplasms | Abstract PDF (Polish) |
| Andrzej Frankiewicz, Grzegorz Helbig, Sławomira Kyrcz-Krzemień | ||
| Vol 12, No 1 (2021) | Tranexamic acid for traumatic brain injury? Old drug raises new debate | Abstract PDF |
| Damian Palus, Aleksandra Cegła, Alan Majeranowski, Andrzej Mital, Michał Krakowiak, Tomasz Szmuda, Paweł Słoniewski | ||
| Vol 10, Supp. C (2019) | Treatment efficacy with brentuximab vedotin in the third-line therapy of primary refractory systemic anaplastic large cell lymphoma ALK(–) | Abstract PDF (Polish) |
| Beata Kania-Zembaczyńska | ||
| Vol 10, No 2 (2019) | Treatment efficacy with brentuximab vedotin in the third-line therapy of primary refractory systemic anaplastic large cell lymphoma ALK(–) | Abstract PDF (Polish) |
| Beata Kania-Zembaczyńska | ||
| Vol 13, No 1 (2022) | Treatment of a patient with acute myeloid leukaemia with FLT3-ITD mutation | Abstract PDF |
| Katarzyna Jerzmanowska, Agnieszka Pluta | ||
| Vol 12, Supp. D (2021) | Treatment of a patient with acute myeloid leukemia with FLT3-ITD mutation | Abstract PDF |
| Katarzyna Jerzmanowska, Agnieszka Pluta | ||
| Vol 2, Supp. B (2011) | Treatment of chronic myeloid leukemia in 2011 — the Polish consensus document | Details PDF (Polish) |
| Frank Giles, Andrzej Hellmann, Jerzy Hołowiecki, Aleksander Skotnicki, Krzysztof Warzocha | ||
| Vol 2, No 1 (2011) | Treatment of chronic myeloid leukemia in pregnant women | Abstract PDF (Polish) |
| Joanna Góra-Tybor | ||
| 476 - 500 of 543 Items | << < 15 16 17 18 19 20 21 22 > >> | |
By VM Media Group sp. z o.o., Grupa Via Medica, ul. Świętokrzyska 73, 80–180 Gdańsk, Poland
phone:+48 58 320 94 94, fax:+48 58 320 94 60, e-mail: viamedica@viamedica.pl
